12:00pm–1:00pm 16 September 2026
Image
Join us as Dr. Aaron Phillips traces the translational journey of a discovery that began in a foundational laboratory and is now advancing through pivotal clinical trials aimed at stabilizing cardiovascular function.
The session includes a conversation with a research participant who received an implanted spinal cord stimulator as part of the trial, offering a rare first person perspective on living with this emerging therapy. Attendees will also see a live demonstration of hind limb negative pressure in a mouse model used to study cardiovascular instability, along with a short lecture outlining the scientific and clinical milestones that transformed a foundational discovery into a human therapy over the past eight years. The discussion highlights both the biological mechanisms and the strategic pathway required to move neuromodulation from bench science to clinical impact.
Key Highlights:
- Watch a live demonstration of hindlimb negative pressure in a mouse model to see real-time cardiovascular assessment.
- Hear directly from a clinical trial participant about living with an implanted spinal cord stimulator.
- Learn the 8-year strategic pathway that took this therapy from foundational bench science to human trials.
When
Wednesday, September 16th, 2026 - 12.00pm ET (Eastern Time - North America) / 9.00am PT (Pacific Time - North America) / 6.00pm CET (Central European Time)
About the speaker:
Image
Aaron Phillips, PhD
Associate Professor
University Calgary
Aaron Phillips, PhD, was trained in biosciences and mathematics. His appreciation of the elegant interactions between the nervous and cardiovascular systems, and how these interactions are disrupted in clinical conditions, has driven his research into the development of novel therapeutics for people with neurological health issues.